Targeting quality improvement activities for depression. Implications of using administrative data - PubMed (original) (raw)
Affiliations
- PMID: 10947139
Multicenter Study
Targeting quality improvement activities for depression. Implications of using administrative data
M Valenstein et al. J Fam Pract. 2000 Aug.
Abstract
Background: Large health care organizations may use administrative data to target primary care patients with depression for quality improvement (QI) activities. However, little is known about the patients who would be identified by these data or the types of QI activities they might need. We describe the clinical characteristics and outcomes of patients identified through administrative data in 2 family practice clinics.
Methods: Patients with depression aged 18 to 65 years were identified through review of encounter/administrative data during a 16-month period. Patients agreeing to participate (N=103) were interviewed with the Primary Care Evaluation of Mental Disorders questionnaire and completed the Depression Outcomes Modules (with an embedded Medical Outcomes Short Form-36 [SF-36]), Symptom Check List-25 (SCL-25), and Alcohol use Disorders Identification Test. Follow-up assessments were completed by 83 patients at a median of 7 months.
Results: A large majority of identified patients (85%) met full criteria for a Diagnostic and Statistical Manual of Mental Disorders depressive disorder; those not meeting criteria usually had high levels of symptoms on the SCL-25. Seventy-seven percent of the patients reported recurrent episodes of depressed mood, and 60% reported chronic depression. Although most improved at follow-up, they continued to have substantial functional deficits on the SF-36, and 60% still had high levels of depressive symptoms.
Conclusions: QI programs that use administrative data to identify primary care patients with depression will select a cohort with relatively severe, recurrent depressive disorders. Most of these patients will receive standard treatments without QI interventions and will continue to be symptomatic. QI programs targeting this population may need to offer intensive alternatives rather than monitor standard care.
Similar articles
- Five-year impact of quality improvement for depression: results of a group-level randomized controlled trial.
Wells K, Sherbourne C, Schoenbaum M, Ettner S, Duan N, Miranda J, Unützer J, Rubenstein L. Wells K, et al. Arch Gen Psychiatry. 2004 Apr;61(4):378-86. doi: 10.1001/archpsyc.61.4.378. Arch Gen Psychiatry. 2004. PMID: 15066896 Clinical Trial. - How a therapy-based quality improvement intervention for depression affected life events and psychological well-being over time: a 9-year longitudinal analysis.
Sherbourne CD, Edelen MO, Zhou A, Bird C, Duan N, Wells KB. Sherbourne CD, et al. Med Care. 2008 Jan;46(1):78-84. doi: 10.1097/MLR.0b013e318148478d. Med Care. 2008. PMID: 18162859 Clinical Trial. - [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
Mouchabac S, Ferreri M, Cabanac F, Bitton M. Mouchabac S, et al. Encephale. 2003 Sep-Oct;29(5):438-44. Encephale. 2003. PMID: 14615693 French. - Depression comes in many disguises to the providers of primary care: recognition and management.
Schuyler D. Schuyler D. J S C Med Assoc. 2000 Jun;96(6):267-75. J S C Med Assoc. 2000. PMID: 10902422 Review. - Depression in primary care. Why do we miss the diagnosis?
Lemelin J, Hotz S, Swensen R, Elmslie T. Lemelin J, et al. Can Fam Physician. 1994 Jan;40:104-8. Can Fam Physician. 1994. PMID: 8312746 Free PMC article. Review.
Cited by
- Sensitivity of Medicaid Claims Data for Identifying Opioid Use Disorder in Patients Admitted to 6 New York City Public Hospitals.
McNeely J, Gallagher SD, Mazumdar M, Appleton N, Fernando J, Owens E, Bone E, Krawczyk N, Dolle J, Marcello RK, Billings J, Wang S. McNeely J, et al. J Addict Med. 2023 May-Jun 01;17(3):339-341. doi: 10.1097/ADM.0000000000001097. Epub 2022 Oct 16. J Addict Med. 2023. PMID: 37267184 Free PMC article. - Prevalence and Medication Treatment of Opioid Use Disorder Among Primary Care Patients with Hepatitis C and HIV.
Tsui JI, Akosile MA, Lapham GT, Boudreau DM, Johnson EA, Bobb JF, Binswanger IA, Yarborough BJH, Glass JE, Rossom RC, Murphy MT, Cunningham CO, Arnsten JH, Thakral M, Saxon AJ, Merrill JO, Samet JH, Bart GB, Campbell CI, Loree AM, Silva A, Stotts AL, Ahmedani B, Braciszewski JM, Hechter RC, Northrup TF, Horigian VE, Bradley KA. Tsui JI, et al. J Gen Intern Med. 2021 Apr;36(4):930-937. doi: 10.1007/s11606-020-06389-7. Epub 2021 Feb 10. J Gen Intern Med. 2021. PMID: 33569735 Free PMC article. - Study protocol for a pragmatic trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) model for engaging patients in opioid use disorder treatment.
McNeely J, Troxel AB, Kunins HV, Shelley D, Lee JD, Walley A, Weinstein ZM, Billings J, Davis NJ, Marcello RK, Schackman BR, Barron C, Bergmann L. McNeely J, et al. Addict Sci Clin Pract. 2019 Feb 19;14(1):5. doi: 10.1186/s13722-019-0135-7. Addict Sci Clin Pract. 2019. PMID: 30777122 Free PMC article. - Trends in the prevalence of depression in hospitalized patients with type 2 diabetes in Spain: analysis of hospital discharge data from 2001 to 2011.
Lopez-de-Andrés A, Jiménez-Trujillo MI, Hernández-Barrera V, de Miguel-Yanes JM, Méndez-Bailón M, Perez-Farinos N, de Burgos Lunar C, Cárdenas-Valladolid J, Salinero-Fort MÁ, Jiménez-García R, Carrasco-Garrido P. Lopez-de-Andrés A, et al. PLoS One. 2015 Feb 23;10(2):e0117346. doi: 10.1371/journal.pone.0117346. eCollection 2015. PLoS One. 2015. PMID: 25706646 Free PMC article. - The predictability of claim-data-based comorbidity-adjusted models could be improved by using medication data.
Bang JH, Hwang SH, Lee EJ, Kim Y. Bang JH, et al. BMC Med Inform Decis Mak. 2013 Nov 20;13:128. doi: 10.1186/1472-6947-13-128. BMC Med Inform Decis Mak. 2013. PMID: 24257030 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous